In summary, chemerin and adiponectin levels in plasma are suggested as independent predictors for vascular stiffness, which promotes the development of subclinical atherosclerosis, and may be applied for the risk assessment of macrovascular diseases in clinical settings. This evidence concerns the gene ADIPOQ and atherosclerosis.